CD151 regulates tumorigenesis by modulating the communication between tumor cells and endothelium

Molecular Cancer Research

Volumn 7, Issue 6, 2009, Pages 787-798

  Sadej, Rafal ^a   Romanska, Hanna ^a   Baldwin, Gouri ^a   Gkirtzimanaki, Katerina ^c   Novitskaya, Vera ^a   Filer, Andrew D ^a   Krcova, Zuzana ^d   Kusinska, Renata ^b   Ehrmann, Jiri ^d   Buckley, Christopher D ^a   Kordek, Radzisław ^b   Potemski, Piotr ^b   Eliopoulos, Aristides G ^c   Lalani, El Nasir ^e   Berditchevski, Fedor ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c UNIVERSITY OF CRETE   (Greece)

^d PALACKÝ UNIVERSITY   (Czech Republic)

^e AGA KHAN UNIVERSITY   (Pakistan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA6BETA4 INTEGRIN; CD151 ANTIGEN; SHORT HAIRPIN RNA; TETRASPANIN; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 3;

ADOLESCENT; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER GROWTH; CANCER MORTALITY; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; CARCINOGENICITY; CELL COMMUNICATION; CELL PROLIFERATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOLOGY; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; SCHOOL CHILD; TUMOR CELL;

ANIMALS; ANTIGENS, CD; BREAST NEOPLASMS; CELL COMMUNICATION; CELL GROWTH PROCESSES; CELL LINE, TUMOR; COLLAGEN; DOWN-REGULATION; DRUG COMBINATIONS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLASTS; HUMANS; INTEGRINS; LAMININ; MICE; MICE, NUDE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROTEOGLYCANS; TISSUE CULTURE TECHNIQUES;

MUS;

EID: 67649595322     PISSN: 15417786     EISSN: None     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-08-0574     Document Type: Article

References (50)

1. Hemler ME. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 2003;19:397-422. (Pubitemid 37487354)
2. Hemler ME. Tetraspanin functions and associated microdomains. Nat Rev Mol Cell Biol 2005;6:801-811 (Pubitemid 41726118)
3. Yunta M, Lazo PA. Tetraspanin proteins as organisers of membrane microdomains and signalling complexes. Cell Signal 2003;15:559-564 (Pubitemid 36385161)
4. Levy S, Shoham T. The tetraspanin web modulates immune-signalling complexes. Nat Rev Immunol 2005;5:136-148 (Pubitemid 40208903)
5. Dong J-T, Lamb PW, Rinker-Schaeffer CW, et al. KAI 1, a metastasis suppressor gene for prostate cancer on human chromosome 11p11.2. Science 1995;268:884-886
6. Takaoka A, Hinoda Y, Sato S, et al. Reduced invasive and metastatic potentials of KAI1-transfected melanoma cells. Jpn J Cancer Res 1998;89:397-404. (Pubitemid 28226920)
7. Yang X, Wei LL, Tang C, et al. Overexpression of KAI1 suppresses in vitro invasiveness and in vivo metastasis in breast cancer cells. Cancer Res 2001;61:5284-5288 (Pubitemid 32681565)
8. Ovalle S, Gutierrez-Lopez MD, Olmo N, et al. The tetraspanin CD9 inhibits the proliferation and tumorigenicity of human colon carcinoma cells. Int J Cancer 2007;121:2140-2152 (Pubitemid 47585592)
9. Ikeyama S, Koyama M, Yamaoko M, et al. Suppression of cell motility and metastasis by transfection with human motility-related protein (MRP-1/CD9) DNA. J Exp Med 1993;177:1231-1237 (Pubitemid 23117114)
10. He B, Liu L, Cook GA, et al. Tetraspanin CD82 attenuates cellular morphogenesis through down-regulating integrin α6-mediated cell adhesion. J Biol Chem 2005;280:3346-3354 (Pubitemid 40223797)
11. Odintsova E, Sugiura T, Berditchevski F. Attenuation of EGF receptor signaling by a metastasis suppressor tetraspanin KAI-1/CD82. Curr Biol 2000;10:1009-1012 (Pubitemid 30689190)
12. Gesierich S, Berezovskiy I, Ryschich E, et al. Systemic induction of the angiogenesis switch by the tetraspanin D6.1A/CO-029. Cancer Res 2006;66:7083-7094 (Pubitemid 44197685)
13. Tokuhara T, Hasegawa H, Hattori N, et al. Clinical significance of CD151 gene expression in non-small cell lung cancer. Clin Cancer Res 2001;7:4109-4114 (Pubitemid 34044635)
14. Ang J, Lijovic M, Ashman LK, et al. CD151 protein expression predicts the clinical outcome of low-grade primary prostate cancer better than histologic grading: a newpr ognostic indicator? Cancer Epidemiol Biomarkers Prev 2004;13:1717-1721
15. Zijlstra A, Lewis J, Degryse B, et al. The inhibition of tumor cell intravasation and subsequent metastasis via regulation of in vivo tumor cell motility by the tetraspanin CD151. Cancer Cell 2008;13:221-234 (Pubitemid 351318371)
16. Kohno M, Hasegawa H, Miyake M, et al. CD151 enhances cell motility and metastasis of cancer cells in the presence of focal adhesion kinase. Int J Cancer 2002;97:336-343 (Pubitemid 34049024)
17. Chometon G, Zhang ZG, Rubinstein E, et al. Dissociation of the complex between CD151 and laminin-binding integrins permits migration of epithelial cells. Exp Cell Res 2006;312:983-995
18. Garcia-Lopez MA, Barreiro O, Garcia-Diez A, et al. Role of tetraspanins CD9 and CD151 in primary melanocyte motility. J Invest Dermatol 2005;125:1001-1009
19. Shigeta M, Sanzen N, Ozawa M, et al. CD151 regulates epithelial cell-cell adhesion through PKC- and Cdc42-dependent actin cytoskeletal reorganization. J Cell Biol 2003;163:165-176 (Pubitemid 37271443)
20. Takeda Y, Kazarov AR, Butterfield CE, et al. Deletion of tetraspanin Cd151 results in decreased pathologic angiogenesis in vivo and in vitro. Blood 2007;109:1524-1532 (Pubitemid 46239585)
21. Yanez-Mo M, Alfranca A, Cabañas C, et al. Regulation of endothelial cell motility by complexes of tetraspan molecules CD81/TAPA-1 and CD151/PETA-3 with α3β1 integrin localized at endothelial lateral junctions. J Cell Biol 1998;141:791-804. (Pubitemid 28217922)
22. Winterwood NE, Varzavand A, Meland MN, et al. A critical role for tetraspanin CD151 in α3β1 and α6β4 integrin-dependent tumor cell functions on laminin-5. Mol Biol Cell 2006;17:2707-2721 (Pubitemid 43825507)
23. Klosek SK, Nakashiro K, Hara S, et al. CD151 forms a functional complex with c-Met in human salivary gland cancer cells. Biochem Biophys Res Commun 2005;336:408-416 (Pubitemid 41267245)
24. Yang XH, Richardson AL, Torres-Arzayus MI, et al. CD151 accelerates breast cancer by regulating α6 integrin function, signaling, and molecular organization. Cancer Res 2008;68:3204-3213
25. Baldwin G, Novitskaya V, Sadej R, et al. Tetraspanin cd151 regulates glycosylation of α3β1 integrin. J Biol Chem 2008;283:35445-35454
26. Gerdes J, Becker MH, Key G, et al. Immunohistological detection of tumour growth fraction (Ki-67 antigen) in formalin-fixed and routinely processed tissues. J Pathol 1992;168:85-86
27. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11:805-815 (Pubitemid 12237981)
28. Mazzetti S, Frigerio S, Gelati M, et al. Lycopersicon esculentum lectin: an effective and versatile endothelial marker of normal and tumoral blood vessels in the central nervous system. Eur J Histochem 2004;48:423-428
29. Luqmani YA, Graham M, Coombes RC. Expression of basic fibroblast growth factor, FGFR1 and FGFR2 in normal and malignant human breast, and comparison with other normal tissues. Br J Cancer 1992;66:273-280
30. Zhang W, Ran S, Sambade M, et al. A monoclonal antibody that blocks VEGF binding to VEGFR2 (KDR/Flk-1) inhibits vascular expression of Flk-1 and tumor growth in an orthotopic human breast cancer model. Angiogenesis 2002;5:35-44. (Pubitemid 36076921)
31. Kazarov AR, Yang X, Stipp CS, et al. An extracellular site on tetraspanin CD151 determines α3 and α6 integrin-dependent cellular morphology. J Cell Biol 2002;158:1299-1309
32. Sugiura T, Berditchevski F. Function of a3b1-tetraspanin protein complexes in tumor cell invasion. Evidence for the role of the complexes in production of matrix metalloproteinase 2 (MMP-2). J Cell Biol 1999;146:1375-1389 (Pubitemid 29477702)
33. Hong IK, Jin YJ, Byun HJ, et al. Homophilic interactions of the tetraspanin CD151 up-regulate motility and MMP-9 expression of human melanoma cells through adhesion-dependent c-jun activation signaling pathways. J Biol Chem 2006;281:24279-24292 (Pubitemid 44274201)
34. Shiomi T, Inoki I, Kataoka F, et al. Pericellular activation of proMMP-7 (promatrilysin-1) through interaction with CD151. Lab Invest 2005;85:1489-1506 (Pubitemid 41662334)
35. Lipscomb EA, Simpson KJ, Lyle SR, et al. The α6β4 integrin maintains the survival of human breast carcinoma cells in vivo. Cancer Res 2005;65:10970-10976 (Pubitemid 41713366)
36. Bon G, Folgiero V, Bossi G, et al. Loss of β4 integrin subunit reduces the tumorigenicity of MCF7 mammary cells and causes apoptosis upon hormone deprivation. Clin Cancer Res 2006;12:3280-3287 (Pubitemid 43910870)
37. Guo W, Pylayeva Y, Pepe A, et al. β4 integrin amplifies ErbB2 signaling to promote mammary tumorigenesis. Cell 2006;126:489-502. (Pubitemid 44163602)
38. Diaz LK, Cristofanilli M, Zhou X, et al. β4 integrin subunit gene expression correlates with tumor size and nuclear grade in early breast cancer. Mod Pathol 2005;18:1165-1175 (Pubitemid 43079915)
39. Lu S, Simin K, Khan A, et al. Analysis of integrin β4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clin Cancer Res 2008;14:1050-1058 (Pubitemid 351302550)
40. Morini M, Mottolese M, Ferrari N, et al. The α3β1 integrin is associated with mammary carcinoma cell metastasis, invasion, and gelatinase B (MMP-9) activity. Int J Cancer 2000;87:336-342 (Pubitemid 30451643)
41. Trusolino L, Cavassa S, Angelini P, et al. HGF/scatter factor selectively promotes cell invasion by increasing integrin avidity. FASEB J 2000;14: 1629-1640 (Pubitemid 30636566)
42. Kobayashi H, DeBusk LM, Babichev YO, et al. Hepatocyte growth factor mediates angiopoietin-induced smooth muscle cell recruitment. Blood 2006;108:1260-1266 (Pubitemid 44232023)
43. Takami Y, Yamamoto I, Tsubouchi H, et al. Modulation of hepatocyte growth factor induction in human skin fibroblasts by retinoic acid. Biochim Biophys Acta 2005;1743:49-56. (Pubitemid 40380604)
44. Claas C, Seiter S, Claas A, et al. Association between the rat homologue of CO-029, a metastasis-associated tetraspanin molecule and consumption coagulopathy. J Cell Biol 1998;141:267-280 (Pubitemid 28182657)
45. Bajou K, Lewalle JM, Martinez CR, et al. Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression. Int J Cancer 2002;100:501-506 (Pubitemid 34816148)
46. Sorlie T. Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 2004;40:2667-2675 (Pubitemid 39574720)
47. Filer A, Parsonage G, Smith E, et al. Differential survival of leukocyte subsets mediated by synovial, bone marrow, and skin fibroblasts: site-specific versus activation-dependent survival of T cells and neutrophils. Arthritis Rheum 2006;54:2096-2108 (Pubitemid 44051065)
48. Berditchevski F, Chang S, Bodorova J, Hemler ME. Generation of Monoclonal Antibodies to Integrin-associated Proteins. Evidence that α3 β1 complexes with emmprin/basigin/OX47/M6. J Biol Chem 1997;272:29174-29180 (Pubitemid 27498208)
49. Fox SB, Leek RD, Smith K, Hollyer J, Greenall M, Harris AL. Tumor angiogenesis in node-negative breast carcinomas-relationship with epidermal growth factor receptor, estrogen receptor, and survival. Breast Cancer Res Treat 1994;29:109-116 (Pubitemid 24104842)
50. McCarty KS, Jr., Miller LS, Cox EB, et al. Estrogen receptor analyses. Correlation of biochemical and immunohistochemical methods using monoclonal antireceptor antibodies. Arch Pathol Lab Med 1985;109:716-721